ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.99
0.30%
US Tech 100
20,426.80
-0.31%
S&P 500
5,969.75
-0.26%
US Dollar vs CAD
1.40285
0.25%
Bitcoin
89,532.01
-1.14%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Repligen Corp (RGEN) Share Price

Repligen Corp

Repligen Corp (RGEN)

NASDAQ
145.68
-4.79
( -3.18% )
Updated: 12:05:56
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
145.68
Bid
145.45
Ask
145.71
Volume
322,964
144.79 Day's Range 149.88
113.50 52 Week Range 211.13
Market Cap
8.159B
Previous Close
150.47
Open
148.58
Last Trade
10
@
145.4719
Last Trade Time
12:06:03
Financial Volume
US$ 47,516,905
VWAP
147.1276
Average Volume (3m)
669,366
Shares Outstanding
56,006,498
Dividend Yield
-
PE Ratio
197.32
Earnings Per Share (EPS)
0.74
Revenue
669.33M
Net Profit
41.58M

About Repligen Corp

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceuti... Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.repligen.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Repligen Corp is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RGEN. The last closing price for Repligen was US$150.47. Over the last year, Repligen shares have traded in a share price range of US$ 113.50 to US$ 211.13.

Repligen currently has 56,006,498 shares outstanding. The market capitalization of Repligen is US$8.43 billion. Repligen has a price to earnings ratio (PE ratio) of 197.32.

Ask ADVFN Intelligence (AI)

Repligen (RGEN) Options Flow Summary

RGEN Options Flow

Overall Flow

Bullish

Net Premium

278k

Calls / Puts

100.00%

Buys / Sells

133.33%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

RGEN Latest News

More News

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

November 12 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 12 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 12 2024
Edgar (US Regulatory)

Repligen Reports Third Quarter 2024 Financial Results

Third quarter reported revenue of $155 million, an increase of 10% year-over-yearCDMO revenue and orders both up ~20% year-over-yearOverall order intake outpaced sales by 4% Full year revenue...

November 12 2024
GlobeNewswire Inc.

Repligen Corporation to Present at Upcoming Investor Conferences

WALTHAM, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be...

November 05 2024
GlobeNewswire Inc.

Repligen to Report Third Quarter 2024 Financial Results

WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2024 financial results on Tuesday, November...

October 31 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

October 23 2024
Edgar (US Regulatory)

Repligen Opens Training & Innovation Center to Elevate Customer Experience

WALTHAM, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening...

September 24 2024
GlobeNewswire Inc.

Form 8-K - Current report

September 18 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

September 12 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.420.289136720363145.26154.48137.27810675146.09263967CS
4-5.52-3.65079365079151.2154.48133.56604769142.72265951CS
12-7.8-5.08209538702153.48154.48133.34669366143.61966849CS
26-20.05-12.0979907078165.73176.94113.5748183142.80972234CS
52-7.32-4.78431372549153211.13113.5646513157.65824881CS
156-114.27-43.9584535488259.95300.23110.45582977170.62114287CS
26062.8275.814627081882.86327.3278.41526192168.30468459CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MTEMMolecular Templates Inc
US$ 0.7681
(138.47%)
266.01M
AGFYAgrify Corporation
US$ 16.35
(56.76%)
1.11M
OMEROmeros Corporation
US$ 6.3934
(52.59%)
11.63M
QUBTQuantum Computing Inc
US$ 3.7601
(41.36%)
151.88M
IFRXInflaRx NV
US$ 2.2808
(33.38%)
1.21M
SOWGSow Good Inc
US$ 4.10
(-58.21%)
2M
NVCTNuvectis Pharma Inc
US$ 6.12
(-42.64%)
1.3M
TRNRInteractive Strength Inc
US$ 3.70
(-36.54%)
1.11M
VISLVislink Technologies Inc
US$ 4.41
(-33.18%)
82.7k
OPRXOptimizeRx Corporation
US$ 4.11
(-33.17%)
1.31M
ELABElevai Labs Inc
US$ 0.02645
(7.09%)
1.59B
XTIAXTI Aerospace Inc
US$ 0.0644
(12.59%)
324.57M
MTEMMolecular Templates Inc
US$ 0.7565
(134.86%)
266.19M
SVMHSRIVARU Holding Ltd
US$ 0.0279
(15.29%)
219.74M
QUBTQuantum Computing Inc
US$ 3.77
(41.73%)
147.61M

RGEN Discussion

View Posts
Monksdream Monksdream 3 weeks ago
RGEN under $200
šŸ‘ļø0
Monksdream Monksdream 2 months ago
RGEN under $200
šŸ‘ļø0
Monksdream Monksdream 4 months ago
RGEN under $200
šŸ‘ļø0
Monksdream Monksdream 7 months ago
RGEN over $30
šŸ‘ļø0
Monksdream Monksdream 9 months ago
RGEN new 52 week high
šŸ‘ļø0
Dennisb68 Dennisb68 10 months ago
Hoping it holds.
šŸ‘ļø0
Monksdream Monksdream 10 months ago
RGEN new 52 week high
šŸ‘ļø0
Dennisb68 Dennisb68 11 months ago
Another very good day for RGEN. Up 6.8%
šŸ‘ļø0
Dennisb68 Dennisb68 1 year ago
Good day for RGEN. Hope we see more of them.
šŸ‘ļø0
Dennisb68 Dennisb68 2 years ago
Do these execs ever BUY the stock?
šŸ‘ļø0
Dennisb68 Dennisb68 2 years ago
It had great earning last quarter.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Good day. Over $300 at one point.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
She continues to make new highs almost daily.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Another new closing high. It just gets better and better.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
New high, $300.00 in AH trading.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Still making new highs almost daily.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
It continues to make new highs...
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Today was the biggest gain ever for RGEN.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
WOW, What a quarter!
https://finance.yahoo.com/news/repligen-reports-second-quarter-2021-113000794.html
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Lost a little ground today. Back below $205.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Still holding above $205 and after the recent run I'm happy with that.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Good to see the stock above $205 again.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
HC Wainwright & Co. boosted the price target for Repligen Corporation
RGEN 0.53%
from $168 to $225.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
RGEN hit a new all time high today.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Actually it a little more than doubled in 2020. It closed 2019 at 92.50 and it closed 2020 at 191.63 for a 107% gain. If it doubles again in 2021 I will be paying a LOT of taxes.
šŸ‘ļø0
Jamins Jamins 4 years ago
222.06 today. Doubled in value in 2020 and company says it will do it again in 2021. So what do you got to lose?
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
RGEN having a great day but not seeing any news to justify it. Perhaps news of an acquisition is coming?
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
I sold half my shares at $159 and was able to get back in at $143. If we get a nice run higher I my sell again and wait for a dip to get back in. Just watching it day by day.
šŸ‘ļø0
keepemcloser keepemcloser 4 years ago
Same here,we feel comfortable at this level.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Great earnings and the stock closes at another all time high.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Stock closed at another all time closing high.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Moved higher in AH trading.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
The stock continues to make new highs. $170 and headed for $200.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
RGEN hit a new 52 week high today.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Thank you. Yes a very nice profit as I bought these at about $3.50 a share. I'm still holding quite a few shares.
šŸ‘ļø0
Hitman970 Hitman970 4 years ago
Nice profit! I am new here and long!
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Sold half my position this morning. Like the stock but feel the markets are due for a dip.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Up another $2 in AH trading. Hope it holds. I think we could see $165 in the near future. What I would love to see the company do is a stock split about 1 for 5 or 1 for 8. I have talked to the company and they have said they have given it some thought but nothing yet.
šŸ‘ļø0
Hitman970 Hitman970 4 years ago
Holding for the big move
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Are you still holding your share after today's run?
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Earnings:

https://www.otcmarkets.com/filing/html?id=14296416&guid=d5eFUHutqUUibth
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Earning out and they are GREAT..

šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Another very nice day. Currently trading over $140,00
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
$139.00 in Pre Mkt. this morning.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
The majority of the stocks I trade are OTC stocks.
šŸ‘ļø0
Hitman970 Hitman970 4 years ago
TDA and E*TRADE charge no fees on non otcs
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Really? Check your statement to see if you aren't paying any fees.
šŸ‘ļø0
Hitman970 Hitman970 4 years ago
BTW no brokers charge commission fees anymore.
šŸ‘ļø0
Hitman970 Hitman970 4 years ago
Yes of course. Iā€™m not wealthy and am 37. Just began investing in this after lengthy due diligence led me here.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
When I buy stocks I pay a $7 commission if I buy 1 share or 100 shares. If I bought 1 share for $130 it would cost me $137 with commission. And then when I sold it I would have to pay another $7 in commission so I would have to sell that stock I bought for $130 for $144 just to break even.
šŸ‘ļø0

Your Recent History

NASDAQ
RGEN
Repligen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved